加拿大pc

病原生物學與微生物學系

來源 : 0916032     發布時間 : 2018-03-07    瀏覽次數 : 6098

科研特色

近(jin)年來承擔了近(jin)百項(xiang)(xiang)(xiang)國(guo)(guo)家(jia)自(zi)(zi)然(ran)科學基金重(zhong)(zhong)點項(xiang)(xiang)(xiang)目(mu)、863計劃項(xiang)(xiang)(xiang)目(mu)、新藥創制(zhi)國(guo)(guo)家(jia)重(zhong)(zhong)大專項(xiang)(xiang)(xiang)、國(guo)(guo)家(jia)自(zi)(zi)然(ran)科學基金面(mian)上(shang)項(xiang)(xiang)(xiang)目(mu)、973計劃子(zi)課(ke)(ke)題、傳染(ran)病國(guo)(guo)家(jia)科技(ji)重(zhong)(zhong)大專項(xiang)(xiang)(xiang)子(zi)課(ke)(ke)題以及(ji)浙江省(sheng)自(zi)(zi)然(ran)科學基金和重(zhong)(zhong)大橫向合作項(xiang)(xiang)(xiang)目(mu)。發(fa)表SCI論(lun)文500余篇,獲得省(sheng)部級科技(ji)成果獎(jiang)一(yi)等獎(jiang)2項(xiang)(xiang)(xiang)、二等獎(jiang)7項(xiang)(xiang)(xiang)以及(ji)國(guo)(guo)家(jia)發(fa)明專利30余項(xiang)(xiang)(xiang),支(zhi)撐合作企(qi)業(ye)獲得多項(xiang)(xiang)(xiang)國(guo)(guo)家(jia)新藥證書和重(zhong)(zhong)點新產品。

本系有人(ren)獸(shou)共(gong)患病(bing)原(yuan)微(wei)生(sheng)(sheng)(sheng)物(wu)(wu)(wu)分(fen)子致(zhi)(zhi)病(bing)機制(zhi)(zhi)與(yu)新(xin)型疫苗(miao)、性傳播病(bing)原(yuan)微(wei)生(sheng)(sheng)(sheng)物(wu)(wu)(wu)分(fen)子致(zhi)(zhi)病(bing)機制(zhi)(zhi)與(yu)新(xin)型疫苗(miao)、細菌耐藥(yao)(yao)(yao)與(yu)膜相關分(fen)子致(zhi)(zhi)病(bing)機制(zhi)(zhi)、皰(pao)疹病(bing)毒分(fen)子致(zhi)(zhi)病(bing)機制(zhi)(zhi)和新(xin)型抗病(bing)毒藥(yao)(yao)(yao)物(wu)(wu)(wu)、微(wei)生(sheng)(sheng)(sheng)物(wu)(wu)(wu)合(he)成(cheng)生(sheng)(sheng)(sheng)物(wu)(wu)(wu)學(xue)、微(wei)生(sheng)(sheng)(sheng)物(wu)(wu)(wu)制(zhi)(zhi)藥(yao)(yao)(yao)、微(wei)生(sheng)(sheng)(sheng)物(wu)(wu)(wu)生(sheng)(sheng)(sheng)物(wu)(wu)(wu)信息學(xue)與(yu)組(zu)合(he)藥(yao)(yao)(yao)物(wu)(wu)(wu)設計、微(wei)生(sheng)(sheng)(sheng)物(wu)(wu)(wu)生(sheng)(sheng)(sheng)物(wu)(wu)(wu)催(cui)化與(yu)生(sheng)(sheng)(sheng)物(wu)(wu)(wu)轉(zhuan)化等(deng)9個PI團隊,其(qi)中微(wei)生(sheng)(sheng)(sheng)物(wu)(wu)(wu)合(he)成(cheng)生(sheng)(sheng)(sheng)物(wu)(wu)(wu)學(xue)、病(bing)原(yuan)微(wei)生(sheng)(sheng)(sheng)物(wu)(wu)(wu)學(xue)等(deng)研究方(fang)向在(zai)學(xue)術(shu)領域內(nei)具(ju)有較好的影響。

教學特色

(1)本科生(sheng)課程: 醫學(xue)微生(sheng)物學(xue)、生(sheng)物化學(xue)、醫學(xue)寄生(sheng)蟲(chong)學(xue)、生(sheng)物芯片原理(li)及數(shu)據分(fen)析、生(sheng)命科學(xue)與(yu)技術實驗(yan)等(deng);

(2)留學本科(ke)生課程: Medical Microbiology、Medical Parasitology;

(3)研究生(sheng)(sheng)(sheng)課(ke)程: 分子病原(yuan)生(sheng)(sheng)(sheng)物(wu)(wu)(wu)(wu)學(xue)、病原(yuan)生(sheng)(sheng)(sheng)物(wu)(wu)(wu)(wu)學(xue)專題、微(wei)(wei)生(sheng)(sheng)(sheng)物(wu)(wu)(wu)(wu)合成生(sheng)(sheng)(sheng)物(wu)(wu)(wu)(wu)學(xue)、微(wei)(wei)生(sheng)(sheng)(sheng)物(wu)(wu)(wu)(wu)生(sheng)(sheng)(sheng)物(wu)(wu)(wu)(wu)信息學(xue)、微(wei)(wei)生(sheng)(sheng)(sheng)物(wu)(wu)(wu)(wu)制藥(yao)工程、細胞培養技術(shu)、生(sheng)(sheng)(sheng)物(wu)(wu)(wu)(wu)技術(shu)制藥(yao)前沿(yan)。

研究生培養方(fang)向

(1)人(ren)獸共患(huan)病(bing)(bing)原微生物分(fen)子致病(bing)(bing)機制(zhi)與新型基(ji)因工程疫苗研發(fa);

(2)性傳(chuan)播病原微生物(wu)分子致病機制與(yu)新型疫苗研發;

(3)細菌耐(nai)藥與膜相關分子(zi)致病機(ji)制;

(4)皰(pao)疹(zhen)病毒分子致病機制與新型抗病毒藥物(wu)研發(fa);

(5)微(wei)生物合成生物學(xue);

(6)微生物制藥;

(7)微生物生物信息學(xue)與組合藥物設計;

(8)微生物(wu)生物(wu)催化與生物(wu)轉化;

(9)微(wei)生物(wu)天然(ran)產物(wu)化學生物(wu)學。


加拿大pc